2017 annual financial data
Ultragenyx Pharmaceutical 2017 Operating margin
Ultragenyx Pharmaceutical 2017 operating margin with verified reported values.
Direct answer
Operating margin was -12,593.49%.
Operating income was -328,942,000 USD and net income was -302,139,000 USD.
Operating cash flow was -253,843,000 USD.
Get free Ultragenyx Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,612,000 USD
- Operating income
- -328,942,000 USD
- Net income
- -302,139,000 USD
- Operating cash flow
- -253,843,000 USD